MedPath

Testosterone Cypionate

Testosterone Cypionate Injection, USP CIII

Approved
Approval ID

58ff6e0d-cc0a-4455-8254-d883d26a3b6d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 6, 2019

Manufacturers
FDA

Wilshire Pharmaceuticals

DUNS: 078657245

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

testosterone cypionate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52536-625
Application NumberANDA206368
Product Classification
M
Marketing Category
C73584
G
Generic Name
testosterone cypionate
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateMay 10, 2019
FDA Product Classification

INGREDIENTS (4)

testosterone cypionateActive
Quantity: 200 mg in 1 mL
Code: M0XW1UBI14
Classification: ACTIB
benzyl benzoateInactive
Code: N863NB338G
Classification: IACT
benzyl alcoholInactive
Code: LKG8494WBH
Classification: IACT
cottonseed oilInactive
Code: H3E878020N
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Testosterone Cypionate - FDA Drug Approval Details